The Mayo Clinic and eight other health organizations launched the Advancing Clinical Trials at the Point of Care Coalition (ACT @ POC) to improve patient care by providing clinicians with high quality clinical research evidence in real time to better evaluate treatments and therapeutics will. The ACT @ POC coalition will bring together health systems, community care organizations, health research organizations, and a more diverse group of patients and providers to help design adaptive clinical trials and develop digital health tools that make clinical trials easier to conduct and more accessible to patients.
The complexity and cost of traditional clinical trials hamper patient and provider participation, the identification of effective treatments for disease, and the acceleration of new clinical discoveries and discoveries. This coalition aims to promote the conduct of large-scale clinical trials at the community level – in the offices and care facilities of healthcare providers that care for most of the people in the United States.
The founding members of the coalition explain their joint commitment in an open letter.
Founding members of ACT @ POC are:
- Mayo Clinic
- Duke Margolis Center for Health Policy
- MITER Corp.
- CURE Drug Repurposing Collaboratory (Critical Path Institute, National Center for Advancing Translational Sciences and US Food and Drug Administration)
- Emory-Morningside Center for Innovative and Affordable Medicine
- Intermountain health
- University of California, Irvine
- Duke University Health System
- Broad Institute of Massachusetts Institute of Technology and Harvard University
“The vast majority of patients and their providers do not participate in clinical trials,” said Mark McClellan, MD, PhD, director of the Duke-Margolis Center for Health Policy and co-founder of ACT @ POC. “With its more accessible, cheaper and more inclusive approach, the [coalition] will help the clinical trial company answer priority research questions related to COVID-19, prepare for future public health emergencies, and address common diseases that have long unmet medical needs, including cardiovascular and neurological disorders.
“The answers to many research questions are in the data, enabling patient engagement in underserved communities that are often excluded from traditional clinical research studies,” said Brian Anderson, MD, chief digital health physician at MITER Corp. “By working with clinicians who are the trusted caregivers of underserved communities, we hope to engage and reach out to people through this collaboration to find new answers to many public health diseases.”
Edited by Gary Cramer